Better than antibiotics, it is being used in contact lenses to prevent infections and biomedical products are the next stage The superbugs have met their match. Conceived at Nanyang Technological University (NTU), it comes in the form of a coating whic…
Category: News
Topical Aganirsen Found To Be Active In Retinal Disease
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced that positive data from a study of aganirsen (GS-101, eye drops) in a nonhuman primate model of choroidal neovascularization has been p…
New Advances In Treating Inherited Retinal Diseases
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in …
Bill Would Repeal SGR, Phase Out Medicare Fee-for-Service
The proposal would pay for the payment overhaul with savings from the military pullback in Afghanistan and Iraq, making it even more of a long shot in a highly partisan election year. Medscape Medical News
Retinal Microchip Restores Vision in Retinitis Pigmentosa
A subretinal microchip technology appears to restore “useful” vision to patients with retinitis pigmentosa, but long-term studies are still needed. Medscape Medical News
New Study Also Finds AMD Agents Equal (CME/CE)
(MedPage Today) — A head-to-head comparison between bevacizumab (Avastin) and ranibizumab (Lucentis) for wet age-related macular degeneration adds to mounting evidence that both agents are equals in improving visual acuity, British researchers reported.
Human Gene Therapy highlights new advances in human retinal disease
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in …
Metformin For Diabetes May Treat Uveitis, A Leading Cause Of Blindness
University of Texas Medical Branch at Galveston researchers have discovered that a drug already prescribed to millions of people with diabetes could also have another important use: treating one of the world’s leading causes of blindness…
Genetic Predictor For Fuchs’ Corneal Dystrophy Confirmed By Mayo Clinic
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual’s risk of developing the eye condition Fuchs’ dystrophy. The findings were presented at the an…
New EHR Requirements Will Deter Use, Say Med Societies
The AMA and 98 other medical societies say CMS should survey physicians about its meaningful-use incentive program before raising the performance bar. Medscape Medical News
New EHR Requirements Will Deter Use, Say Medical Societies
The American Medical Association and 98 other medical societies say CMS should survey physicians about its meaningful use incentive program before raising the performance bar. Medscape Medical News
Association for Research in Vision and Ophthalmology (ARVO) 2012 Annual Meeting
Read clinically focused news coverage of key developments from the meeting. Medscape Ophthalmology
Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer’s Japanese subsidiary, Bayer Yakuhin, Ltd., and Santen Pharmaceutical Co., Ltd. entered into a co-promotion agreement for EYLEA aflibercept) Injection in Japan.
Brief empathy training program improves resident physicians interactions with patients
Resident physicians’ participation in a brief training program designed to increase empathy with their patients produced significant improvement in how patients perceived their interactions with the residents.
Amakem presents key preclinical data on AMA0076 at ARVO meeting
Amakem NV, a kinase platform company focusing on ophthalmology, presented key preclinical data on its potent, locally active Rho Kinase (ROCK) inhibitor AMA0076 at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting bein…
Wet Age-Related Macular Degeneration Responds Equally To Avastin And Lucentis
The one year results from a study into whether two drug treatments (Lucentis and Avastin), are equally effective in treating neovascular or wet age-related macular degeneration (wet AMD), have been reported at an international research meeting in Fort …
Metformin blocks uveitis in laboratory rats
University of Texas Medical Branch at Galveston researchers have discovered that a drug already prescribed to millions of people with diabetes could also have another important use: treating one of the world’s leading causes of blindness.
Repeating trinucleotide a strong predictor of Fuchs’ dystrophy
Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a strong predictor of an individual’s risk of developing the eye condition Fuchs’ dystrophy. The findings were being presented tod…
Study Proposals Could Reduce Diabetic Retinopathy Screening Costs By Around 25 Percent
Research carried out at the Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, has concluded that it would be a safe and cost-effective strategy to screen people with type 2 diabetes who have not yet developed diabetic retinopath…
Problems In Transport Of Donated Human Retina Led Researchers To Discover New Treatment Path For Eye Disease
Sloppy shipping of a donated human retina to an Indiana University researcher studying a leading cause of vision loss has inadvertently helped uncover a previously undetected mechanism causing the disease. The discovery has led researchers to urge revi…